KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Importance of Creatinine Generation Rate in Estimating Glomerular Filtration Rate

Nguyen MK, Bandaru D. Importance of Creatinine Generation Rate in Estimating Glomerular Filtration Rate. Cureus. 2025 Mar 11;17(3):e80441. doi: 10.7759/cureus.80441. PMID: 40225530; PMCID: PMC11990720.

An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy

Glassock RJ. An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy. Adv Ther. 2025 Apr 12. doi: 10.1007/s12325-025-03187-7. Epub ahead of print.[...]

Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry

Tuttle KR, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Nicholas SB; CURE-CKD Consortium. Population-Level[...]